Aktuelle Ernährungsmedizin 2012; 37(2): 91-106
DOI: 10.1055/s-0031-1277005
© Georg Thieme Verlag KG Stuttgart · New York

Ernährung von Tumorpatienten

Nutrition in Cancer PatientsJ.  Arends1
  • 1Klinik für Tumorbiologie an der Albert-Ludwigs-Universität Freiburg
Further Information

Publication History

Publication Date:
11 April 2012 (online)


Bei Patienten mit aktiver Tumorerkrankung entwickelt sich sehr häufig eine Mangelernährung. Der Gewichtsverlust ist mit einer reduzierten Lebensqualität und Leistungsfähigkeit sowie mit einer eingeschränkten Toleranz für antitumorale Therapien assoziiert. Gastrointestinale Störungen, quälende Schmerzzustände, psychosoziale Belastungen sowie Änderungen des metabolischen Milieus mit einer oft nachweisbaren tumorassoziierten systemischen Inflammationsreaktion führen zu Appetitverlust, verminderter Nahrungs- und Energieaufnahme, Fatigue, reduzierter Mobilität und weiterem Muskel- und Gewichtsverlust. Zentrale Ziele einer Stoffwechsel- und Ernährungsbetreuung onkologischer Patienten sind eine differenzierte Erfassung der Problemsituation, die gezielte Behandlung aller Faktoren, die die Nahrungsaufnahme und -verwertung stören, die Sicherung des erforderlichen Energie- und Nährstoffbedarfs, ein begleitendes Muskeltraining sowie antiinflammatorische und antikatabole Behandlungsansätze.


Malnutrition develops frequently in cancer patients. Weight loss in these patients is associated with impaired quality of life and physical performance and a reduced tolerance of anticancer treatments. Gastrointestinal defects, chronic pain, psycho-social tensions and tumor-associated inflammatory reactions, all contribute to appetite loss, reduced intake of nutrients and energy, fatigue, diminished mobility and further loss of weight and muscles. Major aims of the nutritional and metabolic care of oncologic patients are the following: the careful assessment of the relevant problems; the targeted treatment of all factors interfering with nutritional intake and utilization; ensuring the required supply of nutrients and energy; exercise training; as well as anti-inflammatory and anti-catabolic strategies.


  • 1 Dewys W D, Begg C, Lavin P T et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.  Am J Med. 1980;  69 491-497
  • 2 Andreyev H J, Norman A R, Oates J et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?.  Eur J Cancer. 1998;  34 503-509
  • 3 Ross P J, Ashley S, Norton A et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?.  Br J Cancer. 2004;  90 1905-1911
  • 4 Ravasco P, Monteiro-Grillo I, Vidal P M et al. Cancer: disease and nutrition are key determinants of patients’ quality of life.  Support Care Cancer. 2004;  12 246-252
  • 5 Good R A, West A, Day N K et al. Effects of undernutrition of host cell and organ function.  Cancer Res. 1982;  42 (S 02) 737s-746s
  • 6 Skipworth R JE, Stewart G D, Dejong C HC et al. Pathophysiology of cancer cachexia: much more than host-tumour interaction?.  Clin Nutr. 2007;  26 667-676
  • 7 Montazeri A. Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.  Health Qual Life Outcomes. 2009;  7 102
  • 8 Arends J. Mangelernährung bei Tumorpatienten.  Onkologe. 2008;  14 9-14
  • 9 Evans W J, Morley J E, Argilés J et al. Cachexia: a new definition.  Clin Nutr. 2008;  27 793-799
  • 10 Shizgal H M. The effect of malnutrition on body composition.  Surg Gynecol Obstet. 1981;  152 22-26
  • 11 Cahill G F. Fuel metabolism in starvation.  Annu Rev Nutr. 2006;  26 1-22
  • 12 Lundholm K, Holm G, Scherstén T. Insulin resistance in patients with cancer.  Cancer Res. 1978;  38 4665-4670
  • 13 Pajak B, Orzechowska S, Pijet B et al. Crossroads of cytokine signaling – the chase to stop muscle cachexia.  J Physiol Pharmacol. 2008;  59 (S 09) 251-264
  • 14 Norman K, Stobäus N, Zocher D et al. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer (14.07.2010). Im Internet: http://www.ncbi.nlm.nih.gov/pubmed/20631202 Stand: 20.07.2010
  • 15 Prado C MM, Baracos V E, McCargar L J et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.  Clin Cancer Res. 2007;  13 3264-3268
  • 16 Prado C MM, Lieffers J R, McCargar L J et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.  Lancet Oncol. 2008;  7 629-635
  • 17 Dempsey D T, Feurer I D, Knox L S et al. Energy expenditure in malnourished gastrointestinal cancer patients.  Cancer. 1984;  53 1265-1273
  • 18 Arends J, Bodoky G, Bozzetti F et al. ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology.  Clin Nutr. 2006;  2 245-259
  • 19 Kalm L M, Semba R D. They starved so that others be better fed: remembering Ancel Keys and the Minnesota experiment.  J Nutr. 2005;  135 1347-1352
  • 20 Kotler D P, Tierney A R, Culpepper-Morgan J A et al. Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome.  JPEN J Parenter Enteral Nutr. 1990;  14 454-458
  • 21 Bozzetti F, Arends J, Lundholm K et al. ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology.  Clin Nutr. 2009;  28 445-454
  • 22 Thibault R, Goujon N, Le Gallic E et al. Use of 10-point analogue scales to estimate dietary intake: a prospective study in patients nutritionally at-risk.  Clin Nutr. 2009;  28 134-140
  • 23 Oken M M, Creech R H, Tormey D C et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group.  Am J Clin Oncol. 1982;  5 649-655
  • 24 Jensen G L, Mirtallo J, Compher C et al. Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee.  JPEN J Parenter Enteral Nutr. 2010;  34 156-159
  • 25 Dulloo A G. Regulation of body composition during weight recovery: integrating the control of energy partitioning and thermogenesis.  Clin Nutr. 1997;  16 (S 01) 25-35
  • 26 Streat S J, Beddoe A H, Hill G L. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients.  J Trauma. 1987;  27 262-266
  • 27 Holm E, Kämmerer U. Fette und Kohlenhydrate in Ernährungskonzepten für Tumorpatienten.  Aktuel Ernahrungsmed. 2011;  36 286-298
  • 28 Bruera E, Roca E, Cedaro L et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study.  Cancer Treat Rep. 1985;  69 751-754
  • 29 Maltoni M, Nanni O, Scarpi E et al. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.  Ann Oncol. 2001;  12 289-300
  • 30 Jatoi A, Windschitl H E, Loprinzi C L et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.  J Clin Oncol. 2002;  20 567-573
  • 31 Lundholm K, Daneryd P, Bosaeus I et al. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function.  Cancer. 2004;  100 1967-1977
  • 32 Lundholm K, Daneryd P, Körner U et al. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia.  Int J Oncol. 2004;  24 505-512
  • 33 Lundholm K, Gelin J, Hyltander A et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors.  Cancer Res. 1994;  54 5602-5606
  • 34 Colomer R, Moreno-Nogueira J M, García-Luna P P et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature.  Br J Nutr. 2007;  97 823-831
  • 35 van der Meij B S, Langius J AE, Smit E F et al. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment.  J Nutr. 2010;  140 1774-1780
  • 36 Murphy R A, Mourtzakis M, Chu Q SC et al. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy.  Cancer. 2011;  117 1775-1782
  • 37 Murphy R A, Mourtzakis M, Chu Q SC et al. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer.  Cancer. 2011;  117 3774-3780
  • 38 Adachi S, Takiguchi S, Okada K et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study.  Gastroenterology. 2010;  138 1312-1320
  • 39 Biesalski H K. Mikronährstoffsupplemente bei onkologischen Patienten: Gibt es rationale Gründe?.  Aktuel Ernahrungsmed. 2011;  36 282-285
  • 40 Arends J. Metabolism in cancer patients.  Anticancer Res. 2010;  30 1863-1868
  • 41 Na H-K, Oliynyk S. Effects of physical activity on cancer prevention.  Ann N Y Acad Sci. 2011;  1229 176-183
  • 42 Holmes M D, Chen W Y, Feskanich D et al. Physical activity and survival after breast cancer diagnosis.  JAMA. 2005;  293 2479-2486
  • 43 Meyerhardt J A, Giovannucci E L, Holmes M D et al. Physical activity and survival after colorectal cancer diagnosis.  J Clin Oncol. 2006;  24 3527-3534
  • 44 Meyerhardt J A, Heseltine D, Niedzwiecki D et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.  J Clin Oncol. 2006;  24 3535-3541
  • 45 McCann R M, Hall W J, Groth-Juncker A. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration.  JAMA. 1994;  272 1263-1266

Dr. med. Jann Arends

Klinik für Tumorbiologie an der Albert-Ludwigs-Universität Freiburg

Breisacher Straße 117

79106 Freiburg

Email: arends@tumorbio.uni-freiburg.de